Home/Pipeline/CAR Liposomes

CAR Liposomes

Pulmonary Hypertension

Pre-clinicalActive

Key Facts

Indication

Pulmonary Hypertension

Phase

Pre-clinical

Status

Active

Company

Vascular Biosciences

About Vascular Biosciences

Vascular Biosciences is a private, pre-revenue biotech firm founded in 2004 and based in San Diego. The company operates across three synergistic divisions: a pharmaceutical arm developing the CAR peptide for pulmonary hypertension, COVID-19, and sepsis; an interventional device arm with a novel endoarterial biopsy catheter; and a molecular diagnostics arm for analyzing biopsy samples. Its integrated approach aims to diagnose, monitor, and treat vascular diseases with greater precision, though its lead programs remain in pre-clinical and early development stages.

View full company profile

Therapeutic Areas

Pulmonary Hypertension Sepsis COVID-19 Cardiovascular Disease Acute Respiratory Distress Syndrome

Other Pulmonary Hypertension Drugs

Drug	Company	Phase	Status
Digital Biomarker for PH	electronRx	Early Development	Active
Telaglenastat (Inhaled)	Synhale Therapeutics	Preclinical	Active